Niraparib is an oral medication that belongs to a class of drugs known as PARP inhibitors (Poly ADP-Ribose Polymerase inhibitors). These drugs are designed to interfere with the DNA repair mechanisms in cancer cells, thereby making it harder for these cells to survive and replicate.
